COI is a Venture Capital firm investing in companies and funds across science and technology (e.g., AI / life sciences). COI also provides consulting services to Japanese corporations looking to invest in innovative start-ups.

CSB supports breakthrough research in human phenotyping and the microbiome, investing in new technologies and start-ups.

CNS supports both cutting-edge neuroscience research and companies with their ambitions to bring life-changing solutions to market.

CCI sponsors research and venture philanthropy in the fields of Neuroscience, Systems Biology and Artificial Intelligence.